Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
210.3 EUR | +0.57% |
|
+4.42% | +15.73% |
06-19 | CAC40: falls below 7,600 pts in absence of Wall Street | CF |
06-19 | CAC40: frozen around -0.5% in the absence of W-Street and stats | CF |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Weaknesses
- With an expected P/E ratio at 35.25 and 30.9 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.76 times its current sales, is high.
- The company is highly valued given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.73% | 101B | - | ||
+20.99% | 43.9B | B | ||
-3.28% | 18.22B | B- | ||
-27.64% | 2.02B | D+ | ||
+11.06% | 1.86B | C+ | ||
+19.92% | 1.14B | - | ||
+79.32% | 692M | - | - | |
-10.11% | 651M | - | ||
-44.02% | 628M | B- | ||
-46.97% | 614M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EL Stock
- ESL Stock
- Ratings EssilorLuxottica